ArticleCurrent pharmaceutical design2025

Identification of Novel Selective Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists.

Yuxin Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.